Kleintje66 schreef op 25 augustus 2020 16:05:
Een stukje uit mijn aantekeningen boekje op basis van de clinical trials id. en datum.
NCT04311697. Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)
14-5 final manufacturing
2-6 first patient enrolled
8-6 Expand clinical trail
11-6 Expand Clinical Trial Evaluating RLF-100
24-6 fast track granted
16-7 Data Monitoring Committee has reviewed the findings in the first 30 patients (next 4 weeks)
3-8 Clinical trial showed rapid recovery
NCT04453839. RLF-100 (Aviptadil) Intermediate Population Expanded Access Protocol (SAMICARE) (SAMICARE)
20-8 submission of clinical results from 21 patient study for publication
NCT04360096
11-5 filing of IND for Phase 2/3 Clinical Trial of inhaled RLF-100
6-8 FDA grants inhaled use IND for RLF-100 (aviptadil) (The clinical trial of the inhaled formulation of RLF-100 is expected to begin on or before September 1, 2020.)
MBT NCT04311697 verwacht ik zeer binnenkort nieuws, op 16 juli zou erover 4 weken weer beoordeeld worden.